⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 2, 2024Open Access

Supplementary Figure 10 from Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti–PD-1 Therapy

Natalia Szóstak Luiza Handschuh Anna Samelak-Czajka Katarzyna Tomela Bernadeta Pietrzak Marcin Schmidt Łukasz Galus Jacek Mackiewicz Andrzej Maćkiewicz Piotr Kozłowski Anna Philips

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplementary Figure 10. Relative abundance of selected species in patients that exhibited benefits during anti-PD-1 treatment and patients who did not show benefits (CB vs. NB).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Szóstak et al. (2024) studied this question.

synapsesocial.com/papers/68e70c5ab6db643587686036 https://doi.org/10.1158/2326-6066.25523277.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 10 from Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti–PD-1 Therapy2024
2Supplementary Figure 7 from Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti–PD-1 Therapy2024
3Supplementary Figure 7 from Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti–PD-1 Therapy2024
4Supplementary Figure 11 from Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti–PD-1 Therapy2024
5Supplementary Figure 11 from Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti–PD-1 Therapy2024

Supplementary Figure 8 from Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti–PD-1 Therapy2024
Supplementary Figure 8 from Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti–PD-1 Therapy2024
Supplementary Figure 6 from Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti–PD-1 Therapy2024